<ARTICLE>                     5
<LEGEND>
The Schedule contains summary financial information extracted from Blonder
Tongue Laboratories, Inc. and subsidiaries consolidated statement of earnings
for the three-month period ended March 31, 1996 and Balance Sheet as at
March 31, 1996 and is qualified in its entirety by reference to such financial
statements.
</LEGEND>
                    
<MULTIPLIER>                                     1,000
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                              79
<SECURITIES>                                         0
<RECEIVABLES>                                   10,495
<ALLOWANCES>                                       172
<INVENTORY>                                     15,946
<CURRENT-ASSETS>                                26,967
<PP&E>                                           8,159
<DEPRECIATION>                                   1,375
<TOTAL-ASSETS>                                  34,906
<CURRENT-LIABILITIES>                           10,186
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             8
<OTHER-SE>                                      22,010
<TOTAL-LIABILITY-AND-EQUITY>                    34,906
<SALES>                                         11,572
<TOTAL-REVENUES>                                11,572
<CGS>                                            7,615
<TOTAL-COSTS>                                    7,615
<OTHER-EXPENSES>                                 2,793
<LOSS-PROVISION>                                    15
<INTEREST-EXPENSE>                                 165
<INCOME-PRETAX>                                    984
<INCOME-TAX>                                       394
<INCOME-CONTINUING>                              1,149
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       590
<EPS-PRIMARY>                                      .07
<EPS-DILUTED>                                      .07